Weed (BUDZ) Retained Earnings (2010 - 2026)
Weed's (BUDZ) quarterly Retained Earnings came in at -$86.5 million in Q1 2026, down 1.3% year-on-year from -$87.6 million in Q1 2025, and down 201.65% quarter-over-quarter from $85.1 million in Q4 2025.
Weed (BUDZ) Retained Earnings (2010 - 2026) Analysis & Trends
Weed's Retained Earnings history runs 13 years deep, the most recent figure standing at -$86.5 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 1.3% year-over-year to -$86.5 million in Q1 2026; TTM through Mar 2026 was -$86.5 million, a 1.3% decrease from a year earlier, with the FY2025 full-year figure at $85.1 million, up 1.05% from the prior year.
- Retained Earnings slipped to -$86.5 million in Q1 2026 per BUDZ's latest filing, from $85.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $85.1 million in Q4 2025 and bottomed at -$86.5 million in Q1 2026.
- The 5-year median for Retained Earnings is -$83.2 million (2022), against an average of -$5.3 million.
- Across the five-year window, Retained Earnings jumped 200.37% in 2023 and slumped 201.53% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$84.4 million in 2022, then jumped by 199.36% to $83.8 million in 2023, then increased by 0.42% to $84.2 million in 2024, then advanced by 1.05% to $85.1 million in 2025, then sank by 201.65% to -$86.5 million in 2026.
- Per Business Quant, the three latest BUDZ Retained Earnings figures stand at -$86.5 million (Q1 2026), $85.1 million (Q4 2025), and $84.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 8.83 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | -413.76 Mn |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Weed | 2.77 Mn | 2.77 Mn | - | -86.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.45 Mn |
| Dec 31, 2025 | 85.05 Mn |
| Sep 30, 2025 | 84.48 Mn |
| Jun 30, 2025 | -85.45 Mn |
| Mar 31, 2025 | -85.34 Mn |
| Dec 31, 2024 | 84.17 Mn |
| Sep 30, 2024 | -84.77 Mn |
| Jun 30, 2024 | 84.17 Mn |
| Mar 31, 2024 | -84.56 Mn |
| Dec 31, 2023 | 83.82 Mn |
| Sep 30, 2023 | 83.81 Mn |
| Jun 30, 2023 | -84.73 Mn |
| Mar 31, 2023 | 83.80 Mn |
| Dec 31, 2022 | -84.36 Mn |
| Sep 30, 2022 | -83.50 Mn |
| Jun 30, 2022 | -83.20 Mn |
| Mar 31, 2022 | 83.33 Mn |
| Dec 31, 2021 | -82.83 Mn |
| Sep 30, 2021 | 82.68 Mn |
| Jun 30, 2021 | 82.58 Mn |